Company intelligence / Profile preview
Pharma in Silica
Quebec City, Quebec, Canadapharma-insilica.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
The company has completed preclinical development and pre-regulatory meetings with the FDA and Health Canada. Its lead program OpPacli™, a patented nano-sized silica carrier for paclitaxel chemotherapy targeting solid tumors such as NSCLC, aims to improve efficacy and reduce toxicity. As of October 2024, the company secured $4M investment to prepare for North American clinical trials. No human clinical results yet.
- Therapeutic areas
- Oncology
- Modalities
- Nanomedicinenanoparticle drug delivery (specifically nano-sized silica spheres)cytotoxic drugs (e.g., paclitaxel)
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
03
Partnerships
Collaborates with oncology experts and world-renowned research centers; seeking licensing partnerships with major pharmaceutical companies post-clinical proof-of-concept.
Beyond the preview
Go deeper on Pharma in Silica.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Pharma in Silica.